WILLIAM VEAZEY: Open Payments
NPI 1083338990 · OCALA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,740 in 60 payments from 20 companies in 2025. Trend: 2023 $1,027 · 2024 $1,313 · 2025 $1,740
Food & beverage: $1,740
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 15 | $354 |
| GlaxoSmithKline, LLC. | 9 | $174 |
| Boston Scientific Corporation | 1 | $150 |
| Insmed, Inc. | 8 | $138 |
| ABBVIE INC. | 1 | $124 |
| Phathom Pharmaceuticals, Inc. | 1 | $123 |
| Novo Nordisk Inc | 1 | $121 |
| Inspire Medical Systems, Inc. | 4 | $82 |
| Regeneron Healthcare Solutions, Inc. | 3 | $75 |
| Amgen Inc. | 3 | $71 |
Products named: FASENRA, WATCHMAN FLX, NUCALA, Arikayce, VOQUEZNA, Wegovy, DUPIXENT, TEZSPIRE.
Industry payments across FL — which companies pay providers there.
